Appointments: 817-599-3690


Robotics Involved in Most Urologic Cancer Surgeries

Date: June 5, 2018

Source: Jody A. Charnow, Editor; Renal & Urology News


SAN FRANCISCO—Most surgeries for urologic cancers in the United States today are performed with robotic assistance, according to the first meta-analysis looking at overall trends in the use of robotics in urologic oncology.


Robotic surgeries are associated with less blood loss, fewer perioperative complications, and shorter hospital length of stay compared with open surgery, but it costs more than open surgery and takes longer to perform, the meta-analysis showed.



Annual Urinary Incontinence Screening for Women Recommended

Date: August 15, 2018

Source: Jody A. Charnow, Editor; Renal & Urology News


Women of any age should be screened annually for urinary incontinence (UI) and, if indicated, be referred for further evaluation, according to new guidelines issued by the Women's Preventive Services Initiative (WPSI).


“Urinary incontinence adversely affects health, quality of life, and function for most women at some point in their lives, yet it is underdiagnosed and undertreated in the United States,” the guidelines state. “Standardized screening in routine clinical practice, particularly as part of a preventive health care visit, has the potential to identify affected women and initiate diagnostic evaluations and treatment.”



Urinary Stones, Asthma Linked in Adults

Date: August 23, 2018

Source: Jody A. Charnow, Editor; Renal & Urology News


Urinary stone disease (USD) in adults is associated with an increased likelihood of asthma, according to a new study.


The association is more pronounced among recurrent stone formers, individuals aged 20 to 49 years, persons with diabetes, and those who are obese.



Predicting prostate cancer: Nanotechnology shows promise for more accurate prostate cancer screening and prognosis

Date: March 16, 2015

Source: Northwestern University

Summary: A study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. The prostate-specific antigen (PSA) test was once the recommended screening tool for detecting prostate cancer, but there is now disagreement over the use of this test because it can't predict which men with elevated PSA levels will actually develop an aggressive form of the disease.


A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.


Technology developed by Northwestern University researchers may help solve that quandary by allowing physicians to identify which nascent cancers are likely to escalate into potentially life-threatening malignancies and which ones will remain "indolent," or non-aggressive.



The cause of prostate cancer progression to incurable stage has likely been uncovered

Date: July 20, 2018

Source: Academy of Finland

Summary: Researchers have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism (SNP) rs11672691 influences prostate cancer aggressiveness. Their findings also suggest ways to improve risk stratification and clinical treatment for advanced prostate cancer.


Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism (SNP) rs11672691 influences prostate cancer aggressiveness. Their findings also suggest ways to improve risk stratification and clinical treatment for advanced prostate cancer. The study is published in the journal Cell.


Three billion base pairs in the human genome are nearly identical between any two individuals. Nevertheless, genome sequence variation such as single nucleotide polymorphism does occur in the population, and may have profound effects on an individual's risk of developing various diseases, including prostate cancer. "How human genomic variants cause disease and its progression is in general one of the most compelling puzzles and questions in medicine," says Academy Research Fellow Gong-Hong Wei at Biocenter Oulu in the University of Oulu.




February 2016
Introducing the new UroLift® System Treatment for BPH

Benign Prostatic Hyperplasia, or BPH is a condition in which the prostate enlarges as men get older. Over 70% of men in their 60s have BPH symptoms so it is very common1. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man's quality of life.


The prostate is a male reproductive gland, about the size of a walnut, that produces fluid for semen. The prostate surrounds the urethra, which is the tube that carries urine from the bladder out of the body. As the prostate enlarges, it presses on and blocks the urethra, causing bothersome urinary symptoms such as:


• Frequent need to urinate both day and night

• Weak or slow urinary stream

• A sense that you cannot completely empty your bladder

• Difficulty or delay in starting urination

• Urgent feeling of needing to urinate

• A urinary stream that stops and starts


Dr. Deshmukh is now treating this condition with The UroLift® System treatment.  If you have any of the symptoms listed above call now to schedule an appointment.


The UroLift® System treatment is a minimally invasive approach to treating BPH that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue. Clinical data has shown that the UroLift System treatment is safe and effective in relieving lower urinary tract symptoms due to BPH without any impact to sexual function.



September 2016 Prostate Education Seminar

Dr. Deshmukh spoke at Southside Church of Christ in Mineral wells in a free, open to the public seminar on prostate education sponsored by the church and Accountable Care Now.


Screening and affordable labs were available after the presentation.

2014 9th Annual Pink Luncheon

Benefits the Parker County Health Foundation to fund mammograms and screenings for underserved women of Parker County who would otherwise go without a potentially life-saving screening.  We were honored to be a part of this inspirational event.

Dr. Deshmukh spoke on Interstim Therapy at the August 20th quarterly meeting for the Parker County Medical Society.

Dr. Deshmukh, along with his manager Donna Kerr (left) and marketing representative, Tara Walker, attended the Glen Rose Medical Center Health Fair in August.  Dr. Deshmukh provides free prostate screenings to local men each year as a part of his community involvement.

Exploring the risk factors for prostate cancer


In the United States, one in six men can expect to be diagnosed with prostate cancer, while there is a one in seven chance that a Canadian man will be diagnosed with prostate cancer at some point during his lifetime.


Those elevated incidence rates could be a byproduct of an aging population, as age is a significant risk factor for prostate cancer. According the Prostate Cancer Foundation, one in 10,000 men under age 40 will be diagnosed with prostate cancer. That figure skyrockets to one in 38 for men between the ages of 40 to 59, and one in 15 for men in their 60s.


Though age is perhaps the most significant risk factor, it's not the only thing that increases a man's risk for prostate cancer. In fact, there are a host of factors in addition to age that increase a man's risk for prostate cancer, which the Canadian Cancer Society says will claim the lives of more than 4,000 Canadian men this year.


One such risk factor is where a man lives. Men who live in rural China, for instance, have a relatively low risk of developing prostate cancer during their lifetime. That risk is only 2 percent if a man stays in rural China his entire life. But that risk increases significantly if a Chinese man moves to the West, where a man in the United States has a 17 percent chance of developing prostate cancer.


And not only does which country a man lives in play a role, but also the location of his home within that country's borders can elevate a man's risk for developing prostate cancer. Men who live in cities north of 40 degrees latitude (north of Philadelphia, PA, Columbus, OH, and Provo, UT) have the highest risk of dying from prostate cancer, and researchers feel this is because men who live in such cities get less sunlight during the winter months and therefore less vitamin D.


Race is another risk factor for prostate cancer. Asian men have the lowest risk of developing prostate cancer, while African-American men are 60 percent more likely to develop the disease than Caucasian men. The PCF notes that African-American men are also 2.5 times more likely to die from the disease, which highlights the importance that African-American men must place on screenings.


Family history also plays a role in a man's risk for developing prostate cancer. Men whose fathers or brothers have had prostate cancer are twice as likely to develop the disease. Their risk increases even more if their fathers or brothers were diagnosed with the cancer before reaching the age of 55 or if they had three or more family members who were diagnosed with prostate cancer.


Research into prostate cancer is ongoing and continues to unearth new information regarding this potentially deadly disease. The PCF notes, for instance, that the risk factors for aggressive version of this type of cancer can differ from the risk factors for slow-growing cancers. As a result, risk factors that were once not linked to prostate cancer are now being linked to aggressive forms of the disease.


Smoking, for example, might be a risk factor for aggressive prostate cancer, as is a diet void of vegetables. Neither factor, however, is thought to increase a man's risk of slow-growing prostate cancer. Additional risk factors for aggressive prostate cancer include height (tall men might have an elevated risk) and living a sedentary lifestyle.


Many men are aware of the importance of prostate cancer screenings. However, few might know that certain factors significantly increase their risk for being diagnosed with this potentially deadly disease.


More information about prostate cancer is available at



Enlarged prostate gland common among older men


Many men suffer from an enlarged prostate gland. Because an enlarged prostate most often affects men over the age of 50, many younger men may be unaware of the symptoms of an enlarged prostate.


However, identifying warning signs early can lead to an earlier diagnosis and a more effective course of treatment.


What is an enlarged prostate?

An enlarged prostate, known as prostatitis or sometimes benign prostatic hyperplasia, or BPH, is the inflammation of the prostate. What causes the prostate to expand is largely unknown, but the condition has been linked to a few different factors.


It may occur as a result of a bacterial infection or decreased immune function. Others find it is the result of weakening muscles. Genetics and the aging process also play a role in prostate enlargement. According to, men have a 50 percent chance of getting prostatitis in their lifetimes. Since the condition is so common, some believe that all men could eventually have an enlarged prostate if they live long enough.



Symptoms of an enlarged prostate vary in their severity, and a small amount of inflammation can cause major symptoms and vice versa. Information from the United States National Library of Medicine says less than half of all men with an enlarged prostate actually have symptoms of the disease. Those who do may experience any number of the following:


• Weak or slow urine stream.

• Feeling of incomplete bladder emptying.

• Increased urinary frequency or urgency.

• Testicular pain.

• Pain with ejaculation.

• Straining to urinate.

• Continued dribbling of urine.

• Stopping and starting while urinating.


For many men, the increased frequency to visit the bathroom is one of the first indicators that there may be an issue with the prostate gland. Those who have slept comfortably through the night may now be rising one or two times per night to urinate.


Many times an enlarged prostate, which leads to an inability to fully empty the bladder, can trigger urinary tract infections. This may compound symptoms and cause additional pain or burning when passing urine, as well as increased urinary urgency. An infection also may lead to blood in the urine.


Diagnosing an enlarged prostate

The prostate is a walnut-sized gland located between the bladder and the penis. The prostate secretes fluid that nourishes and protects sperm, and is responsible for pushing this fluid into the urethra prior to ejaculation. The prostate gland's proximity to the bladder and the penis is largely what causes the problems with urination. Also, because of the prostate's location, the single best way to detect enlargement of the gland is through a digital rectal examination, or DRE, during which a doctor will insert his or her finger into the rectum and feel for the prostate to see if it is enlarged or tender. Should there be any indication of an abnormality, a prostate-specific antigen blood test, or PSA, or an ultrasound may be suggested.



Medical treatment often helps alleviate the symptoms of an enlarged prostate. A doctor may prescribe alpha-blockers, which relax the muscles around the urethra to help urine flow more freely. If enlargement is due to infection, antibiotics could be given.


Other medications, such as 5-alpha-reductase inhibitors, reduce the level of a certain form of testosterone called DHT. With less DHT present, the prostate shrinks. If medications do not alleviate symptoms, surgery may be necessary. In some cases, an enlarged prostate may be an indicator of prostate cancer.


A doctor may want to run tests to see if cancer is present. Prostate cancer is often very slow-growing, and some people prefer a wait-and-see method of treatment if symptoms are not troublesome.


Understanding enlarged prostate symptoms can help men with the condition feel better faster.


Copyright © North Central Texas Urology